Bachem Ag | GDUFA | Fees | Self Identification | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Bachem AG
GDUFA

Bachem-PSE

Bachem Reports Strong Sales Growth & Sustained High Profitability

12 Mar 2026

// PRESS RELEASE

A Quick Guide to Biotinylated Peptides

03 Feb 2026

// PRESS RELEASE

The importance of time to market for New Chemical Entities

12 Nov 2025

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Bachem

Contact Supplier

Stanford Drug Discovery Symposium

Attending

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.bachem.com/webinar/peptides-nce/learn-about-methods-for-making-long-and-complex-peptides/

Bachem AG

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2026, Corporate Presentation, Enzymatic Ligation & Technologies: Future of Oligo Manufacturing, Conjugation Chemistry: Oligo Targeted Delivery, CMC Process Development and Risk Mitigation, Scaling Up: Major Investments in Peptide Production 2025, The Online Peptide Guide 2025, Oligonucleotide Generics 2025, Oligonucleotide Therapeutics 2025, SwissMedic GMP 2024, Goserelin Leuprorelin Triptorelin 2025, Pioneering Sustainable, Large-Scale Tides Manufacturing, Maintaining a Resilient Tides Supply Chain Under VUCA Conditions, Leading the Octreotide Scale-up, Scientific Expertise to Spring 2024 Conferences, Commerical Peptide NCE, Quality Grade Building Blocks, Innovations for Tides 2024, GMP Certificate 2023, Gorerelin Leuprorelin Triptorelin 2024, Commercial Peptide NCE 2024, Molecular Hiving™ Technology, Semaglutide 2024, Lanreotide, Back to Stirred Vessels & On to Metric Tons of Oligonucleotides

Product List 2026
Corporate Presentation
Enzymatic Ligation & Technologies: Future of Oligo Manufacturing
Conjugation Chemistry: Oligo Targeted Delivery
CMC Process Development and Risk Mitigation
Scaling Up: Major Investments in Peptide Production 2025
The Online Peptide Guide 2025
Oligonucleotide Generics 2025
Oligonucleotide Therapeutics 2025
SwissMedic GMP 2024
Goserelin Leuprorelin Triptorelin 2025
Pioneering Sustainable, Large-Scale Tides Manufacturing
Maintaining a Resilient Tides Supply Chain Under VUCA Conditions
Leading the Octreotide Scale-up
Scientific Expertise to Spring 2024 Conferences
Commerical Peptide NCE
Quality Grade Building Blocks
Innovations for Tides 2024
GMP Certificate 2023
Gorerelin Leuprorelin Triptorelin 2024
Commercial Peptide NCE 2024
Molecular Hiving™ Technology
Semaglutide 2024
Lanreotide
Back to Stirred Vessels & On to Metric Tons of Oligonucleotides

VIDEO(s)

Acylated Peptide Synthesis- An Analysis of Cost & Capacity, Assess and Reduce Nitrosamine Contamination Risks in Peptide APIs, Avoiding Epimerization in Peptide Synthesis, Development for Novel Peptides: Column Screening to GMP Releases, Going Large-scale with Manufacturing of Oligonucleotides, Large-scale TIDES purification with MCSGP under GMP, Learn About Methods for Making Long and Complex Peptides, Mitigating Supply Chain Risks in an Age of Disruption, More Than White Powder and Reports, Navigating Regulatory Affairs Challenges for Successful Drugs, Peptide Aggregation – A Complex Topic, Regulatory Perspective- Expectations for Peptide Therapeutics, Scalable Oligonucleotide Manufacture With Stirred-bed Technology, Tag-assisted One-pot Liquid-phase Oligonucleotide Synthesis, Expert Round – Upscaling TIDES Manufacturing 2024, New Trends in Oligotherapeutics, 2nd Generation Process for the Manufacturing of Liraglutide, Innovation for Peptide & Oligonucleotide Manufacturing, Peptide-based In Vitro Diagnostics, Generic APIs-Liraglutide & Other GLP-1 Analogues, Oligonucleotide Facility Virtual Tour, Semaglutide, Leading by Experience in Generic API, Customer Testimonial, Continuous Chromatography of Peptides, Expanding into Oligos - Interview, Thiazine Formation: Elucidation of Thiol-Maleimide Side-Reaction, Oligonucleotides - Innovation that Transforms Lives, Interview with Torsten Wohr, The Perfect Ingredients for a Better World, Sherpany and Futurae

Acylated Peptide Synthesis- An Analysis of Cost & Capacity
Assess and Reduce Nitrosamine Contamination Risks in Peptide APIs
Avoiding Epimerization in Peptide Synthesis
Development for Novel Peptides: Column Screening to GMP Releases
Going Large-scale with Manufacturing of Oligonucleotides
Large-scale TIDES purification with MCSGP under GMP
Learn About Methods for Making Long and Complex Peptides
Mitigating Supply Chain Risks in an Age of Disruption
More Than White Powder and Reports
Navigating Regulatory Affairs Challenges for Successful Drugs
Peptide Aggregation – A Complex Topic
Regulatory Perspective- Expectations for Peptide Therapeutics
Scalable Oligonucleotide Manufacture With Stirred-bed Technology
Tag-assisted One-pot Liquid-phase Oligonucleotide Synthesis
Expert Round – Upscaling TIDES Manufacturing 2024
New Trends in Oligotherapeutics
2nd Generation Process for the Manufacturing of Liraglutide
Innovation for Peptide & Oligonucleotide Manufacturing
Peptide-based In Vitro Diagnostics
Generic APIs-Liraglutide & Other GLP-1 Analogues
Oligonucleotide Facility Virtual Tour
Semaglutide
Leading by Experience in Generic API
Customer Testimonial
Continuous Chromatography of Peptides
Expanding into Oligos - Interview
Thiazine Formation: Elucidation of Thiol-Maleimide Side-Reaction
Oligonucleotides - Innovation that Transforms Lives
Interview with Torsten Wohr
The Perfect Ingredients for a Better World
Sherpany and Futurae

DIGITAL CONTENT

56 Corporate Content #SupplierSpotlight, 4 Data Compilation #PharmaFlow, 139 News #PharmaBuzz

56 Corporate Content #SupplierSpotlight
4 Data Compilation #PharmaFlow
139 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

29 All APIs, 17 USDMF, 8 CEP/COS, 9 JDMF, 9 KDMF, 16 NDC API, 2 VMF, 22 Listed APIs

29 All APIs
17 USDMF
8 CEP/COS
9 JDMF
9 KDMF
16 NDC API
2 VMF
22 Listed APIs

KEY PRODUCTS

Atosiban, Buserelin Acetate, Etomidate, Glucagon, Glucagon Hydrochloride, Gonadorelin, Gonadorelin Acetate, Gonadorelin Hydrochloride, Goserelin Acetate, Leuprolide Acetate, Octreotide Acetate, Propofol, Somatostatin, Tetracosactide, Triptorelin Acetate, Triptorelin Pamoate

Atosiban
Buserelin Acetate
Etomidate
Glucagon
Glucagon Hydrochloride
Gonadorelin
Gonadorelin Acetate
Gonadorelin Hydrochloride
Goserelin Acetate
Leuprolide Acetate
Octreotide Acetate
Propofol
Somatostatin
Tetracosactide
Triptorelin Acetate
Triptorelin Pamoate

SERVICES

API Manufacturing, API & Drug Product Development

API Manufacturing
API & Drug Product Development
- 3 API Development

KEY SERVICES

Custom Peptide Synthesis, CMO for Peptide & Oligonucleotide APIs

Custom Peptide Synthesis
CMO for Peptide & Oligonucleotide APIs

INSPECTIONS & REGISTRATIONS

36 FDA, 3 EDQM, 5 GDUFA, 9 Others

36 FDA
3 EDQM
5 GDUFA
9 Others

Xls

Filters

Reset all filters

Filters

FILTER :

filter Registrant Name Reset all filters

5 All

01 1BACHEM SA

02 1Bachem AG

03 3Bachem Americas, Inc.

filter Facility Name Reset all filters

5 All

01 1BACHEM SA

02 1Bachem AG

03 3Bachem Americas, Inc.

filter API Manufacture Reset all filters

5 All

01 5API MANUFACTURE

FDF Manufacture Reset all filters

5 All

01 5Blank

List of Suppliers

ALL
Bachem AG
Bachem Americas, Inc.
BACHEM SA

Supplier Virtual Booth

price-trend

01

GDUFA fees paid

USA

Stanford Drug Discovery Symposium

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Paid in : 2024

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : Bachem AG

Business Address : Hauptstrasse 144 Bubendorf B...

FEI Number : 1000153019

Country : Switzerland

Paid in : 2024

Bachem company banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

GDUFA fees paid

USA

Stanford Drug Discovery Symposium

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Paid in : 2024

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : Bachem Americas, Inc.

Business Address : 3132 Kashiwa Street Torrance...

FEI Number : 2024023

Country : Switzerland

Paid in : 2024

Bachem company banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

GDUFA fees paid

USA

Stanford Drug Discovery Symposium

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Paid in : 2023

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : Bachem Americas, Inc.

Business Address : 1271 Avenida Chelsea Vista C...

FEI Number : 3000718309

Country : Switzerland

Paid in : 2023

Bachem company banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

04

GDUFA fees paid

USA

Stanford Drug Discovery Symposium

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Paid in : 2018

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : Bachem Americas, Inc.

Business Address : 1271 Avenida Chelsea Vista C...

FEI Number : 3012673677

Country : Switzerland

Paid in : 2018

Bachem company banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

05

GDUFA fees paid

USA

Stanford Drug Discovery Symposium

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Paid in : 2024

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : BACHEM SA

Business Address : Succursale de Vionnaz Route ...

FEI Number : 3002808225

Country : Switzerland

Paid in : 2024

Bachem company banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Contact Bachem Ag and get a quotation

Bachem Ag is a supplier offers 26 products (APIs, Excipients or Intermediates).

Find Carbidopa bulk with DMF, CEP, JDMF offered by Bachem Ag

Find Goserelin Acetate bulk with DMF, CEP, JDMF offered by Bachem Ag

Find Leuprolide Acetate bulk with DMF, CEP, JDMF offered by Bachem Ag

Find Octreotide Acetate bulk with DMF, CEP, JDMF offered by Bachem Ag

Find Propofol bulk with DMF, CEP, JDMF offered by Bachem Ag

Find Etomidate bulk with DMF, CEP offered by Bachem Ag

Find Glucagon bulk with DMF, JDMF offered by Bachem Ag

Find Gonadorelin Acetate bulk with DMF, CEP offered by Bachem Ag

Find Buserelin Acetate bulk with JDMF offered by Bachem Ag

Find Goserelin Acetate bulk with DMF offered by Bachem Ag

Find Lanreotide Acetate bulk with DMF offered by Bachem Ag

Find Liraglutide bulk with DMF offered by Bachem Ag

Find Octreotide Acetate bulk with DMF offered by Bachem Ag

Find Somatostatin bulk with CEP offered by Bachem Ag

Find Teriparatide bulk with DMF offered by Bachem Ag

Find Teriparatide Acetate bulk with JDMF offered by Bachem Ag

Find Tetracosactide bulk with DMF offered by Bachem Ag

Find Triptorelin Pamoate bulk with DMF offered by Bachem Ag

Find Atosiban bulk offered by Bachem Ag

Find Glucagon Hydrochloride bulk offered by Bachem Ag

Find Gonadorelin bulk offered by Bachem Ag

Find Gonadorelin Hydrochloride bulk offered by Bachem Ag

Find Leuprolide Mesylate bulk offered by Bachem Ag

Find Octreotide Acetate bulk offered by Bachem Ag

Find Semaglutide bulk offered by Bachem Ag

Find Triptorelin Acetate bulk offered by Bachem Ag

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.